LA MESA, Calif., June 10, 2005 (PRIMEZONE) -- Nicodrops, Inc. (Pink Sheets:NCDP), developer of the drug-free, non-nicotine smoking alternative, herbal dietary supplement, LOZENGE(i), today announced it will be featured in an upcoming in-store sales circular from Walgreens. The in-store sales circular is a weekly promotional piece specifically promoting a number of the better selling products sold at the more than 4,700 Walgreens locations. Nicodrops will be featured in June 12-18 circular at Walgreens. Nicodrops is currently retailing at Walgreens for $9.99. In addition, the Nicodrops ad scheduled to appear in The National Enquirer can be found in the June 20th, 2005 issue on sale NOW and can be seen on page 21.
"Our relationship with the good folks at Walgreens continues to blossom with us being featured as one of the products in their weekly in-store promotional piece for customers," said Christopher Calpito, president and CEO of Nicodrops, Inc. "We are intent on creating in-store traffic at all Walgreens locations and know that will benefit our sales of Nicodrops even further."
Calpito said the company is continuing to look at ways to promote the benefit of Nicodrops through a variety of advertising channels. Walgreens has already scheduled another Nicodrops circular for the back to school period (Early September) in which they will advertise Nicodrops at a reduced price.
About Nicodrops:
Nicodrops Inc., La Mesa, CA, developed a drug-free, non-nicotine product which helps reduce the stress associated with not smoking, using all natural herbs.(i) For more information go to http://www.nicodrops.com or call 1-866-844-5383.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. The words "believe," "expect," "anticipate", and "project," and similar expressions identify forward-looking statements, which speak only as of the date the statement was made. Such statements may include, but not be limited to, projections of revenues, income or loss, expenses, plans, and assumptions relating to the foregoing. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future results could differ materially from those described in forward-looking statements.
(i) These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseases.